loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r0_cep_2021_309___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Seqens

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 WAVELENGTH ENTERPRISES LTD. Petah Tikva IL (1)

    filter

    01 Cetirizine dihydrochloride, Process B (1)

    filter

    01 Israel (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    WAVELENGTH ENTERPRISES LTD. Petah T...

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Cetirizine dihydrochloride, Process B

    PDF Supplier PDF
    URL Supplier Web Content
    R0-CEP 2021-309 - Rev 00
    Valid
    Chemical
    2021-11-24
    1084
    Seqens Company Banner

    CPhI North America

    Exhibiting

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2021-309 - Rev 00 of Wavelength Enterprises Ltd. Petah Tikva Il

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2021-309 - Rev 00 of Wavelength Enterprises Ltd. Petah Tikva Il 1

    20

    Wavelength Enterprises Ltd. Petah Tikva Il, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    One of their significant offerings is Cetirizine dihydrochloride, Process B, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2021-309 - Rev 00

    This Chemical Type CEP, issued on November 24, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1084 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY